Skip to main content
Clinical Trials/NCT06357338
NCT06357338Enrolling By InvitationNot Applicable

Differential Expression and Potential Value of c-MYC in Non-invasive and Invasive Mammary Carcinoma

Marwa Mahmoud Hassan1 site in 1 country70 target enrollmentStarted: March 19, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Sponsor
Enrollment
70
Locations
1
Primary Endpoint
role of c-MYC in breast cancer

Study Overview

Brief Summary

Retrospective observational study to evaluate c-MYC expression in non invasive and invasive mammry carcinoma

Detailed Description

To correlate different levels of c-MYC expressions with variable clinical and pathological parameters of mammary carcinoma (such as patients' ages, tumor grading, staging, laterality, focality and nodal metastasis, co-existing in-situ components). This study will be carried out on archived formalin-fixed and paraffin embedded tissue blocks that were belonged to 70 women with breast lumps.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
15 Years to — (Child, Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Specimens of Modified Radical Mastectomies from breast carcinoma patients

Exclusion Criteria

  • Cases with insufficient clinical data.
  • Tissue blocks of destroyed or insufficient material, unfit for diagnosis.
  • Cases who received pre-operative chemotherapy.

Outcomes

Primary Outcomes

role of c-MYC in breast cancer

Time Frame: 1 year

difference between expression of c-MYC in non invasive and invasive mammary carcinoma

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Marwa Mahmoud Hassan
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Marwa Mahmoud Hassan

resident doctor of pathologu

Sohag University

Study Sites (1)

Loading locations...

Similar Trials